From: Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin
PR
SD
PD
χ2
P value
Nek2B
13.388
0.003a
Negative
6 (50.0%)
4 (33.3%)
2 (16.7%)
Positive
8 (26.7%)
6 (20.0%)
16 (53.3%)